231 related articles for article (PubMed ID: 33011310)
1. Characteristic antimicrobial resistance of clinically isolated Stenotrophomonas maltophilia CYZ via complete genome sequence.
Ma J; Feng J; Shan Y; Zhao Y; Qiao H; Xie L; Lin X; Wang C; Chuai X
J Glob Antimicrob Resist; 2020 Dec; 23():186-193. PubMed ID: 33011310
[TBL] [Abstract][Full Text] [Related]
2. Analysis of multidrug-resistant determinants of clinically isolated Acinetobacter baumannii CYZ via whole genome sequencing.
Chuai X; Zhou Y; Feng J; Yu M; Wu Y; Han L; Zhao Y; Qiao H; Gao Z; Li J; Xie L; Zhao W; Wang C
Microbiol Immunol; 2023 Sep; 67(9):396-403. PubMed ID: 37403254
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance genes prediction via whole genome sequence analysis of Stenotrophomonas maltophilia.
Shahid S; Abid R; Ajmal W; Almuqbil M; Almadani ME; Khan Y; Ansari AA; Rani R; Alshehri A; Alghamdi A; Asdaq SMB; Ghazanfar S
J Infect Public Health; 2024 Feb; 17(2):236-244. PubMed ID: 38128408
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant Stenotrophomonas maltophilia: Description of new MLST profiles and resistance and virulence genes using whole-genome sequencing.
Rizek CF; Jonas D; Garcia Paez JI; Rosa JF; Perdigão Neto LV; Martins RR; Moreno LZ; Rossi Junior A; Levin AS; Costa SF
J Glob Antimicrob Resist; 2018 Dec; 15():212-214. PubMed ID: 30036694
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of phenotypical and genotypical methods for the identification and typing of Stenotrophomonas maltophilia isolated from a pharmaceutical facility.
de Miranda RVDSL; Monteiro GM; da Costa LV; Dos Santos MCS; Dos Reis CMF; Braga LMPDS; Forsythe SJ; Villas Bôas MHS; Brandão MLL
J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37838475
[TBL] [Abstract][Full Text] [Related]
6. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.
Crossman LC; Gould VC; Dow JM; Vernikos GS; Okazaki A; Sebaihia M; Saunders D; Arrowsmith C; Carver T; Peters N; Adlem E; Kerhornou A; Lord A; Murphy L; Seeger K; Squares R; Rutter S; Quail MA; Rajandream MA; Harris D; Churcher C; Bentley SD; Parkhill J; Thomson NR; Avison MB
Genome Biol; 2008 Apr; 9(4):R74. PubMed ID: 18419807
[TBL] [Abstract][Full Text] [Related]
7. Comparative insights into multiple drug resistance determinants in Stenotrophomonas maltophilia MER1.
Xie L; Zhou A; Zhao J; Tang Y; Zhao R; Zhou Y; Cao G; Zhong C; Li J
J Glob Antimicrob Resist; 2021 Dec; 27():20-25. PubMed ID: 34365056
[TBL] [Abstract][Full Text] [Related]
8. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
[TBL] [Abstract][Full Text] [Related]
9. Genomic insights into evolution of extensive drug resistance in Stenotrophomonas maltophilia complex.
Kumar S; Bansal K; Patil PP; Kaur A; Kaur S; Jaswal V; Gautam V; Patil PB
Genomics; 2020 Nov; 112(6):4171-4178. PubMed ID: 32653516
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
[TBL] [Abstract][Full Text] [Related]
12.
Alcaraz E; Centrón D; Camicia G; Quiroga MP; Di Conza J; Passerini de Rossi B
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258754
[No Abstract] [Full Text] [Related]
13. Stenotrophomonas maltophilia in Malaysia: molecular epidemiology and trimethoprim-sulfamethoxazole resistance.
Neela V; Rankouhi SZ; van Belkum A; Goering RV; Awang R
Int J Infect Dis; 2012 Aug; 16(8):e603-7. PubMed ID: 22698885
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
16. Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity.
Flores-Treviño S; Gutiérrez-Ferman JL; Morfín-Otero R; Rodríguez-Noriega E; Estrada-Rivadeneyra D; Rivas-Morales C; Llaca-Díaz JM; Camacho-Ortíz A; Mendoza-Olazarán S; Garza-González E
J Med Microbiol; 2014 Nov; 63(Pt 11):1524-1530. PubMed ID: 25165124
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates.
Bostanghadiri N; Ardebili A; Ghalavand Z; Teymouri S; Mirzarazi M; Goudarzi M; Ghasemi E; Hashemi A
BMC Res Notes; 2021 Apr; 14(1):151. PubMed ID: 33879237
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics.
Blanco P; Hjort K; Martínez JL; Andersson DI
mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081
[TBL] [Abstract][Full Text] [Related]
19. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
